As of 2025-04-18, the Relative Valuation of Evolent Health Inc (EVH) is (23.48) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.96 USD, the upside of Evolent Health Inc based on Relative Valuation is -362.1%.
The range of the Relative Valuation is (22.08) - (22.16) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 41.8x - 49.4x | 49.2x |
| Forward P/E multiples | 32.5x - 41.9x | 39.6x |
| Fair Price | (22.08) - (22.16) | (23.48) |
| Upside | -346.5% - -347.3% | -362.1% |
| Date | P/E |
| 2025-04-17 | -16.95 |
| 2025-04-16 | -17.46 |
| 2025-04-15 | -17.58 |
| 2025-04-14 | -18.52 |
| 2025-04-11 | -18.98 |
| 2025-04-10 | -18.71 |
| 2025-04-09 | -18.92 |
| 2025-04-08 | -18.07 |
| 2025-04-07 | -17.78 |
| 2025-04-04 | -18.90 |
| 2025-04-03 | -19.07 |
| 2025-04-02 | -19.05 |
| 2025-04-01 | -18.31 |
| 2025-03-31 | -17.92 |
| 2025-03-28 | -18.16 |
| 2025-03-27 | -18.22 |
| 2025-03-26 | -17.88 |
| 2025-03-25 | -17.65 |
| 2025-03-24 | -18.31 |
| 2025-03-21 | -18.13 |
| 2025-03-20 | -18.84 |
| 2025-03-19 | -19.09 |
| 2025-03-18 | -19.18 |
| 2025-03-17 | -18.90 |
| 2025-03-14 | -17.80 |
| 2025-03-13 | -18.05 |
| 2025-03-12 | -17.94 |
| 2025-03-11 | -17.77 |
| 2025-03-10 | -17.22 |
| 2025-03-07 | -17.01 |
| 2025-03-06 | -17.61 |
| 2025-03-05 | -16.54 |
| 2025-03-04 | -16.18 |
| 2025-03-03 | -16.59 |
| 2025-02-28 | -17.01 |
| 2025-02-27 | -16.42 |
| 2025-02-26 | -17.88 |
| 2025-02-25 | -19.81 |
| 2025-02-24 | -19.26 |
| 2025-02-21 | -19.73 |
| 2025-02-20 | -20.26 |
| 2025-02-19 | -19.90 |
| 2025-02-18 | -19.15 |
| 2025-02-14 | -18.96 |
| 2025-02-13 | -18.86 |
| 2025-02-12 | -18.16 |
| 2025-02-11 | -18.66 |
| 2025-02-10 | -18.81 |
| 2025-02-07 | -18.64 |
| 2025-02-06 | -18.52 |